Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. - Wikidata - awgldk - TriplyDB

Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration.

Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration.

http://www.wikidata.org/entity/Q33253340

about

Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issue Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo Synaptojanin-1 plays a key role in astrogliogenesis: possible relevance for Down's syndrome Solving the puzzle of Parkinson's disease using induced pluripotent stem cells.A cross-study transcriptional analysis of Parkinson's disease.Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity.Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.Proliferative reactive gliosis is compatible with glial metabolic support and neuronal function.Hypothyroidism affects astrocyte and microglial morphology in type 2 diabetes Enhanced brain distribution of modified aspartoacylase.Autophagy, inflammation and neurodegenerative disease.Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).Comparison of alpha-synuclein immunoreactivity in the spinal cord between the adult and aged beagle dog.Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation.Immunological features of alpha-synuclein in Parkinson's disease.Multiple system atrophy: a primary oligodendrogliopathy.Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice.Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.Astrocytes: a central element in neurological diseases.Physiological and pathological roles of exosomes in the nervous system.Review: Roles for astrocytes in epilepsy: insights from malformations of cortical development.Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells.Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression.Leukoencephalomyelopathy of mature captive cheetahs and other large felids: a novel neurodegenerative disease that came and went?The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging.Comparison of α-synuclein immunoreactivity in the hippocampus between the adult and aged beagle dogs.Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral s Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes.Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes.Diversity of astroglial responses across human neurodegenerative disorders and brain aging.Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson's Disease.

P2860

Q24621854-1DD562A9-BC4E-4B9F-B3AC-76236F57F5B6 Q26852041-8E44C194-C562-4347-B05F-248DDAA866BE Q27300819-8D04F972-4F82-40E9-A7FB-10A250830240 Q28578459-A812D90A-B920-4BA8-9B21-554E5702B85B Q33358637-B9A81AD8-8062-49DF-B92F-58F479630FC1 Q33420377-842C09F3-BB3C-4FF1-B198-BAED3F9E052C Q33726660-FD383008-9E73-4156-9F6C-E302E68B3A84 Q33735667-63C5F62C-DEE6-4E69-AFA9-A77CE72F8D12 Q33889585-D808775F-898C-40F4-89B6-D17462BC4C8C Q34045171-81F30829-92E9-4403-A98E-98B1B91BB104 Q34095468-29725538-6912-4E5B-837F-5FB5D8AECFE2 Q34616189-D0FCB071-E6BF-4058-93E6-0F3F734626C2 Q34686890-157A5D6D-C419-4310-964B-DE94BC5642F7 Q35666953-E32BD49E-7CC2-4BE9-9BDA-692BD8C398DF Q36033271-755B2559-57CB-465C-AC97-6CECE9312F56 Q36313225-78C5B2ED-AC6F-4295-8527-07D2F37B45E8 Q36453886-F4C757E7-CA71-49D2-82B2-0DDA63464D27 Q37232067-38473AC1-EA60-4602-A2AE-3D6DC3E1118C Q37282526-0FE9C9F9-7619-4B2D-821C-544F51BDD52C Q37555992-F9AC5A86-D557-4C87-9B81-1E866F862F9F Q37874476-1AD99500-4E30-460A-B40E-9CECC1131991 Q38241183-C360D4D0-9FAF-4033-82A0-738922482B35 Q38670385-A411D548-7277-43EA-8F75-434B4996FC8D Q38712290-84394F43-8C93-457B-8773-4272B88CD59C Q38852428-4F1CA82E-3E95-4379-A993-347D858E29C4 Q39033667-D055AD14-32AB-4FB6-89A1-EB0BA9491315 Q39426452-3862817D-7740-4D55-AE20-4644BB11D492 Q41173187-1A7F7CC7-F96F-4602-A1BE-00C345BD7563 Q42244061-C86C1F4F-ED23-465F-9637-8795C847D40A Q42522017-7E41EDC5-247B-4DB4-96DC-C558A35D079F Q43483324-D3AE9366-6534-40FA-9767-90DD05D13691 Q44946186-E3EB3C5F-3647-4E8A-B3D9-84681EB46DA6 Q46243605-40E901BD-4872-437F-B48C-ECBB0ECB6E9D Q47144356-1767C5C6-A790-4386-9839-84C191BCEB53 Q47929663-02692CF6-FDC3-4442-AF3A-A60565580FD6 Q53392035-20DDDB58-ACD7-4B18-BC21-968BB3C9C35D Q55085565-B83CEDFF-C687-412E-BD93-AA4C38BDFFAD

P2860

Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration.

http://www.wikidata.org/entity/Q33253340

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Glial degeneration and reactiv ...... t of primary gliodegeneration.

@ast

Glial degeneration and reactiv ...... t of primary gliodegeneration.

@en

type

label

Glial degeneration and reactiv ...... t of primary gliodegeneration.

@ast

Glial degeneration and reactiv ...... t of primary gliodegeneration.

@en

prefLabel

Glial degeneration and reactiv ...... t of primary gliodegeneration.

@ast

Glial degeneration and reactiv ...... t of primary gliodegeneration.

@en

P1433

Q33253340-22E14413-FD0C-4F2C-951B-DE40254A415C

P1476

Q33253340-60F93BC6-78DC-4DC1-B06C-78C90A1F1EC0

P2093

Q33253340-B4B5C7EB-31B7-4DD0-AFEB-91A7DE2CD6F9

Q33253340-D7E50EA9-621A-44A5-B682-D39D08E67D9B

P2860

Q33253340-17807D70-C720-46D8-8C72-36F1F85A29DE

Q33253340-27F59F60-7FF2-4BA6-A86F-D4ABDCAD78B3

Q33253340-3283971C-2977-43A2-AE75-D62236767AE2

Q33253340-3A3E5A20-C149-4F67-B7C7-B49B5C5C25EC

Q33253340-3EC9AE2B-8CAA-47CD-9760-85426E3E41B1

Q33253340-412EECCF-C710-4A26-BF52-95FFEC43D791

Q33253340-456745C6-DB2B-474A-A6B9-BDC8EFB6AC62

Q33253340-617A5793-28A2-4502-A6B9-DC4EC3258C3A

Q33253340-75D0028F-F490-48B6-8A33-E827A432552B

Q33253340-92FB697F-9514-4ED9-A2B2-4F01D58E177F

P2888

Q33253340-9113D15C-6FB3-4614-958D-7441D8ADE1D9

P304

Q33253340-D73A9578-372F-4566-9122-6E993D3A90F0

P31

Q33253340-FFF43496-0F90-4AE7-8F4A-F0075766119E

P356

Q33253340-C33E21B1-DD96-4D2B-B64C-1AAB877A97B8

P433

Q33253340-98931FEF-23F5-4807-902B-65E108AF01D2

P478

Q33253340-9E6B33D1-1E84-4DBA-BEF5-A88A3631BA7E

P577

Q33253340-4DD76AF2-7F7C-493E-8800-230D68029BF1

P6179

Q33253340-6B3C4D65-4F1D-48FF-92B9-D71B808489A1

P698

Q33253340-2E7B62E7-73BA-44F0-9145-7BDBAC2911B1

P356

S00401-006-0119-Z

P1433

Acta Neuropathologica

P1476

Glial degeneration and reactiv ...... t of primary gliodegeneration.

@en

P2093

Emilie Croisier

http://www.w3.org/2001/XMLSchema#string

Manuel B Graeber

http://www.w3.org/2001/XMLSchema#string

P2860

Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

Widespread alterations of alpha-synuclein in multiple system atrophy

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.

Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.

Myelin degeneration in multiple system atrophy detected by unique antibodies.

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Microglia in the aging brain.

Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

P2888

s00401-006-0119-z

P304

517-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-006-0119-Z

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047356676

http://www.w3.org/2001/XMLSchema#string

P698

16896905

http://www.w3.org/2001/XMLSchema#string